Breaking News Headlines Today | Ground News

See every side of every news story

MedPage Today image

News from MedPage Today

New York, United States

Stay current with all the latest and breaking news from MedPage Today. Compare headlines and media bias behind news outlets on stories breaking today.

Overall, we’ve indexed 959 stories from MedPage Today over the past 3 months.

MedPage Today’s media bias is Center. Ground News assigned this score by aggregating media bias ratings of a Center rating from Ad Fontes Media, a Center rating from Media Bias/Fact Check .

Is MedPage Today credible or reliable? Our Factuality score answers both of those questions. When it comes to MedPage Today, we’ve assigned a Very High factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about MedPage Today

Where is MedPage Today located?New York, United StatesMedPage Today's Website

Media Bias Ratings

Average Bias Rating:

Center

Center

byAd Fontes Media

Center

byMedia Bias/Fact Check

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top MedPage Today News

Doctors and public health organizations sue Kennedy over vaccine policy changes

Vaccines · United States

Doctors and public health organizations sue Kennedy over vaccine policy changes

63% Center coverage: 171 sources

American kids have become increasingly unhealthy over nearly two decades, new study finds

Health · United States

American kids have become increasingly unhealthy over nearly two decades, new study finds

65% Center coverage: 151 sources

Obesity drug prices are dropping, but getting a steady supply remains a challenge

Health · Calgary

Obesity drug prices are dropping, but getting a steady supply remains a challenge

73% Center coverage: 59 sources

Blindspots

Trump’s Policy Megabill Cuts More Than $1 Trillion From Medicaid: Here’s How

Iowa City Crisis Service Line Plans Layoffs as Government Halts 988 Support for LGBTQ+ Youth

53% Center coverage: 21 sources

CommUnity Crisis Services in Iowa City will layoff employees in response to government shut down of LGBTQ+ youth-specific 988 hotline,Donald Trump · United States See the Story

The Worst of Trump's 'Big Beautiful Bill' Will Be Felt in Rural America

75% Left coverage: 4 sources

The law contains far-reaching changes to health policyDonald Trump · United States See the Story

Large Study Shows No Ties Between Ever Using Birth Control Pills and Liver Cancer

100% Center coverage: 1 sources

(MedPage Today) -- There was little association, if any, between ever using oral contraceptives and the risk of liver cancer, a large population-based study showed. Across two U.K. prospective cohorts, ever-use compared with never-use of oral...United Kingdom · United Kingdom See the Story

Higher Education May Be a Double-Edged Sword in Alzheimer's

100% Center coverage: 1 sources

(MedPage Today) -- Higher education appeared to protect against tau accumulation during the amyloid-negative stages of Alzheimer's disease but was associated with accelerated tau accumulation in amyloid-positive stages, data from three cohorts...Higher Education See the Story

Study: Yes, Psoriasis Progression to PsA Can Be Stopped

100% Center coverage: 1 sources

(MedPage Today) -- Tumor necrosis factor (TNF) inhibitor therapy was effective in reducing the likelihood that psoriasis would progress to psoriatic arthritis (PsA), a retrospective study indicated. Among propensity-matched patients with severe...United States · United States See the Story

Clinical Trial Sheds Light on Daily CBD Use and Liver Enzymes

67% Left coverage: 3 sources

(MedPage Today) -- Daily use of cannabidiol (CBD) at doses commonly reported by consumers was associated with potentially dangerous increases in liver enzymes, a randomized clinical trial found. Among 201 healthy adult participants followed for...United States · United States See the Story

Getting to Complete Response With Less Toxicity in HER2-Positive Early Breast Cancer

100% Center coverage: 1 sources

(MedPage Today) -- In the DESTINY-Breast11 (DB11) trial, trastuzumab deruxtecan (T-DXd, Enhertu), followed by the taxane paclitaxel (Taxol), trastuzumab (Herceptin), and pertuzumab (Perjeta) in combination (THP), improved pathologic complete response...Cancer See the Story

First Targeted Therapy for Exon 20 Insertions in NSCLC Wins FDA Accelerated Approval

100% Center coverage: 1 sources

(MedPage Today) -- The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell lung cancer (NSCLC) associated with EGFR exon 20 insertions, the agency said. The approval stipulates...United States · United States See the Story

Breaking News Topics Related to MedPage Today